Dexamethasone Preconditioning in Cardiac Procedures Reduces Decreased Antithrombin Activity and Is Associated to Beneficial Outcomes: Role of Endothelium-Reference-Cited by-同舟云学术

Dexamethasone Preconditioning in Cardiac Procedures Reduces Decreased Antithrombin Activity and Is Associated to Beneficial Outcomes: Role of Endothelium

Published:2018-09-25 Issue: Volume:9 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Muedra Vicente,Moreno Lucrecia,Rodilla Vicente,Arce Cristina,Montó Fermi,Blázquez Águeda,Pérez Paloma,D’Ocón Pilar

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference55 articles.

1. Recombinant human antithrombin III restores heparin responsive–ness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass.;Avidan;J. Thorac. Cardiovasc. Surg.,2005

2. Oxidized antithrombin is a dual inhibitor of coagulation and angiogenesis: importance of low heparin affinity.;Azhar;Int. J. Biol. Macromol.,2016

3. Glucorticoids as modulators of expression and activity of Antithrombin (At): potential clinical relevance.;Barettino;Thromb. Res.,2015

4. Degradation of the endothelial glycocalyx in clinical setting: searching for the sheddases.;Becker;Br. J. Clin. Pharmacol.,2015

5. Role of heparin and non heparin binding serpins in coagulation and angiogenesis: a complex interplay.;Bhakuni;Arch Biochem. Biophys.,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Neuroprotective Role of Sugammadex: A Clinical Study on Cognitive Function Assessment in an Enhanced Recovery After Cardiac Surgery Approach and an Experimental Study;Frontiers in Cellular Neuroscience;2022-02-21

2. Hypoxia Increases Nitric Oxide-Dependent Inhibition of Angiogenic Growth;International Journal of Translational Medicine;2021-12-08

3. Metabolomic assessment of mechanisms underlying anti-renal fibrosis properties of petroleum ether extract from Amygdalus mongolica;Pharmaceutical Biology;2021-01-01